BPC-157 and TB-500: the recovery peptide stack

Introduction

BPC-157 and TB-500 are arguably the two most studied peptides in recovery research. Each is compelling on its own, but many researchers study them together — often called the "recovery stack" — because their mechanisms complement each other.

BPC-157: Body Protection Compound

BPC-157 is a 15-amino-acid fragment derived from gastric juice protein. It's researched for:

• Tendon and ligament healing
• Gut lining repair
• Angiogenesis (new blood vessel formation)
• Inflammation modulation

BPC-157 is known for its stability at body temperature and resistance to enzymatic degradation, making it unusual among peptides.

TB-500: Thymosin Beta-4 fragment

TB-500 is a synthetic fragment of Thymosin Beta-4. It's researched for:

• Muscle tissue repair
• Actin regulation (cell migration)
• Systemic anti-inflammatory effects
• Soft-tissue injury recovery

Where BPC-157 is often described as acting locally on the injury site, TB-500 tends to be studied for more systemic distribution.

Why the stack?

Researchers combine the two because:

• BPC-157 supports localized, targeted healing
• TB-500 supports systemic cellular mobility and repair
• Together they may address both the injury and the surrounding tissue environment

The stack is largely used in animal tendon/ligament recovery studies. Human research is more limited, which is why rigorous, well-documented protocols matter.

Research considerations

• Both peptides ship lyophilized and require bacteriostatic water reconstitution
• Dosing ranges vary widely in the literature — always use a calculator
• Always verify 99%+ purity with a COA before beginning

Conclusion

BPC-157 and TB-500 are the backbone of modern recovery peptide research. Whether studied individually or as a stack, meticulous documentation and high-purity compounds are non-negotiable.